Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 162 publications
Multiomic analyses delineate human neuroendocrine tumor cell states in relation to normal enteroendocrine cell ontogeny.
Journal: The Journal of clinical investigation
Published: May 21, 2026
Safety of immune checkpoint inhibitors in a diverse patient population: a single-institution experience.
Journal: Ecancermedicalscience
Published: November 06, 2025
Multiomic analyses delineate human neuroendocrine tumor cell states in relation to normal enteroendocrine cell ontogeny.
Journal: The Journal of clinical investigation
Published: July 09, 2025
Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 01, 2025
Phase II trial of cabozantinib in combination with nivolumab for advanced extrapancreatic neuroendocrine tumors (epNET).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 01, 2025
Case report of a transcatheter pulmonic valve-in-valve replacement through a bioprosthetic tricuspid valve in a patient with carcinoid heart disease.
Journal: European heart journal. Case reports
Published: April 15, 2025
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.
Journal: The New England journal of medicine
Published: September 16, 2024
Diagnosis and Management of Parathyroid Carcinoma.
Journal: Clinical pharmacology and therapeutics
Published: May 13, 2024
Corrigendum to "Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours" [Eur J Cancer 188 (2023) 39-48].
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 12, 2024
Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors.
Journal: Science advances
Published: September 27, 2023
The impact of immune-related adverse events on survival outcomes in a racially diverse population, with a focus on non-Hispanic Black patients.
Journal: The oncologist
Published: June 18, 2023
Last Updated: 09/26/2026